Pharmacoeconomic Aspects of Treating Childhood Pneumonia - Cost of Illness Study Based on Data from Serbia
, , , , y
11 abr 2024
Acerca de este artículo
Publicado en línea: 11 abr 2024
Páginas: 57 - 62
Recibido: 26 abr 2021
Aceptado: 19 jul 2021
DOI: https://doi.org/10.2478/sjecr-2021-0040
Palabras clave
© 2024 Marina J. Kostić et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Kostić, Marina J.
University of Kragujevac, Faculty of Medical Sciences, Department of Pharmacology and ToxicologyKragujevac, Serbia
Vučković, Živan M.
University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of PharmacyKragujevac, Serbia
Desnica, Jana V.
University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of DentistryKragujevac, Serbia
Knežević, Sanja M.
University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of PediatricsKragujevac, Serbia
Knežević, Jasmina
University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of PediatricsKragujevac, Serbia
Janković, Slobodan M.
University of Kragujevac, Faculty of Medical Sciences, Department of Pharmacology and ToxicologyKragujevac, Serbia